{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-044160","form_type":"8-K","ticker":"PULM","cik":"0001574235","company_name":"Pulmatrix, Inc.","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.841700+00:00","generated_at":"2026-05-30T02:49:09.658629+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Pulmatrix Q3 2024 revenue down 79% YoY to $0.4M; cash runway into Q4 2026","bullets":["Net loss $2.6M ($0.71 per share) vs $3.8M ($1.03) in Q3 2023.","Revenue fell to $0.4M from $1.8M due to PUR1900 wind down; R&D expenses cut 80% to $0.8M.","Cash and equivalents $10.8M; company expects funding into Q4 2026.","Completed wind down of PUR1900 Phase 2b; no further financial obligation, to receive 2% royalties ex-US.","Closed MannKind cross-license for iSPERSE technology; pursuing strategic alternatives."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-044160","json":"https://secwatch.observer/filing/0001493152-24-044160.json","markdown":"https://secwatch.observer/filing/0001493152-24-044160.md","text":"https://secwatch.observer/filing/0001493152-24-044160.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574235/000149315224044160/0001493152-24-044160-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574235/000149315224044160/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:49:09.658629+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}